Novo Nordisk
NVO
NVO
1,779 hedge funds and large institutions have $39.7B invested in Novo Nordisk in 2024 Q3 according to their latest regulatory filings, with 146 funds opening new positions, 705 increasing their positions, 644 reducing their positions, and 203 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less first-time investments, than exits
New positions opened: 146 | Existing positions closed: 203
30% less funds holding in top 10
Funds holding in top 10: 90 → 63 (-27)
32% less call options, than puts
Call options by funds: $791M | Put options by funds: $1.16B
Holders
1,779
Holding in Top 10
63
Calls
$791M
Puts
$1.16B
Top Buyers
| 1 | +$430M | |
| 2 | +$240M | |
| 3 | +$128M | |
| 4 |
D.E. Shaw & Co
New York
|
+$115M |
| 5 |
MIF
Mediolanum International Funds
Dublin 1,
Ireland
|
+$110M |
Top Sellers
| 1 | -$208M | |
| 2 | -$194M | |
| 3 | -$156M | |
| 4 |
Jennison Associates
New York
|
-$137M |
| 5 |
Renaissance Technologies
New York
|
-$130M |